Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if interferon-alpha2a is superior to the standard
treatment with cyclosporin A for the treatment of severe ocular manifestations of Behcet's
disease.